Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by steadfaston Oct 31, 2014 5:28pm

219 Views

Post# 23083797

MD & A

IS impressive. The April 22nd NR indicated it could be year-end before the
efficacy results and it is confirmed in MD&A in 2014, could be tomorrow, could
be Dec 31st.

I have waited this long another 2 months is ok. As long as it is worth waiting for, that
is all that matters.

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles